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Abstract
The regulatory mechanisms underlying pulsatile secretion are complex, especially as it is partly controlled by other
hormones and the combined action of multiple agents. Regulatory relations between hormones are not directly observable
but may be deduced from time series measurements of plasma hormone concentrations. Variation in plasma hormone
levels are the resultant of secretion and clearance from the circulation. A strategy is proposed to extract inhibition,
activation, thresholds and circadian synchronicity from concentration data, using particular association methods. Time
delayed associations between hormone concentrations and/or extracted secretion pulse profiles reveal the information on
regulatory mechanisms. The above mentioned regulatory mechanisms are illustrated with simulated data. Additionally, data
from a lean cohort of healthy control subjects is used to illustrate activation (ACTH and cortisol) and circadian synchronicity
(ACTH and TSH) in real data. The simulation and the real data both consist of 145 equidistant samples per individual,
matching a 24-hr time span with 10 minute intervals. The results of the simulation and the real data are in concordance.
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Introduction
Hormones are important agents in the regulation of physiolog-
ical processes. Endocrine glands, producing hormones [1,2], often
secrete their product in short well-synchronized bursts, referred to
as episodic secretion [3]. The episodic secretion depends on the
circadian rhythm but also involves a strong stochastic component
[4–6]. Secretion results in changes in hormone levels, usually
leading to critical modulation of tissue function triggering the
secretion of other hormones.
Hormones can thus be seen as an ensemble of initiators and
inhibitors that critically modulate physiological processes. This
paper refers to regulatory mechanisms in the strict context of
actions between hormones, which can be initiatory, inhibitory or
both. It has been shown [1,7] that these regulatory relations
between hormones are subject to the physiological state, e.g., age,
gender, lifestyle and pathology, and thus exhibit some inter- and
intra-individual variability. Characterizing these regulatory mech-
anisms can give insight in how the implementation of regulation
varies among different individuals, and how such is influenced by
pathology or (drug) treatment.
Ideally, characterizing the regulatory mechanisms should be
based on fundamental physiological and kinetic models in which
the parameters are estimated from dynamic data obtained through
an optimal experimental design. Unfortunately, prior knowledge
about the interactions, constants, modalities, and (inter)dependen-
cies required for this model-based approach is often lacking and,
hence, optimal experimental designs can not be defined. Common
experiments are either intervention studies where the response of
one hormone to another hormone is registered in an infusion
experiment or time-resolved serum hormone concentrations under
standard physiological conditions. The infusion experiments are
laborious, invasive and do not necessarily reflect normal
physiological conditions. Time-resolved concentration measure-
ments, on the other hand, do not have these disadvantages. They
also contain information about regulation albeit in a concealed
form.
In this paper, we present a strategy to recover information on
regulation from time series of serum hormone concentrations.
More exactly, what is aimed for is to extract global information on
regulatory mechanisms, such as inhibition, activation, thresholds,
and circadian synchronicity. This strategy uses a set of global
measures, that can summarize the relations between hormone
time profiles. From these summarizing measures regulatory
patterns can be inferred. The introduced measures are a set of
cross-correlation profiles of the hormone time series. Considering
simulated hormone times series of which the generating regulatory
mechanism is known, it can be shown that different types of
regulatory behavior result in different types of cross-correlation
profiles. Additionally, a confirmation of the suitability of the
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which regulatory mechanisms are well understood.
The information obtained on regulatory mechanisms from these
measures can be exploited in several ways. From a theoretical
perspective, it can be used to improve time series sampling
schemes, or suggest developments in the field of fundamental
mechanistic models. More importantly, from a practical perspec-
tive, it can serve as a tool to characterize variations in regulation
between individuals or detect changes related to pathophysiology.
Materials and Methods
Endocrine time series
In observing cohorts of subjects with different features (age, sex,
phenotype, lifestyle) the hormone ensemble is likely differentially
regulated. Being able to characterize cohorts of subjects having a
disease or lifestyle feature in common, a normality study on
regulation helps to mark normal regulation and aids to distinguish
it from non-normal regulation. A group of nine lean healthy
volunteers, age 40+7:2 year and body mass index was
21:75+1:05 (mean + SD), consisting of four women (not
pregnant and in the early follicular phase), and five men, was
used in this study. The subjects were asked to refrain from
strenuous physical exercise, and did not use any hormonal
medication. The data are part of a normality study performed
by the Department of Endocrinology of the Leiden University
Medical Center, the ethical committee approved the study. All
participants gave written consent. The sampling scheme com-
prised drawing 145 whole blood samples with 10 minute intervals
over a 24-hour period. The data of this study include six hormones
(adrenocorticotropic hormone (ACTH), cortisol, thyroid-stimulat-
ing hormone (TSH), luteinizing hormone (LH), follicle-stimulating
hormone (FSH), and growth hormone (GH)), where quantification
of hormone concentrations was performed with sensitive immu-
noassays. The motivation for using the lean cohort in this paper
was to show the endocrine relations in healthy lean subjects. These
and other statistics about the cohort are summarized in Table 1.
Assay characteristics
Growth hormone, PRL, TSH, LH and FSH were all measured
by time-resolved fluoroimmunoassays (IFMA) (Delfia, PerkinEl-
mer-Wallac Oy, Turku, Finland). The standard (Genotropin) used
in the GH assay was obtained from Pharmacia and Upjohn,
Uppsala, Sweden, and calibrated against World Health Organi-
zation (WHO) Second Standard International Reference Prepa-
ration, IRP 80/505.The detection limit is 0:0038mg=L. The intra-
assay coefficient of variation (CV) is 1.6–8.4%. Prolactin was
calibrated against the 3rd WHO standard IRP 84/500. The
detection limit is 0:04mg=L and the intra-assay CV 3–5.5%.
Thyrotropin was calibrated against IRP 80/558. The detection
limit is 0:05mU=L and the intra-assay CV v5%. LH assay is
calibrated against LH standard 80/552. Detection limit is
0:02IU=L, intra-assay CV v3%. FSH is calibrated against IRP
94/632. The detection limit is 0:02IU=L, and the intra-assay CV
v3%. ACTH was measured with an immunoradiometric assay
(IRMA) (Nichols Institute Diagnostics, San Juan Capistrano, CA,
USA). The detection limit is 2ng=L, and the intra-assay CV is
between 2.8–7.5%. Cortisol was measured with a radioimmuno-
assay (DiaSorin, Stillwater, MN, USA). The detection limit is
25nmol=L, and the intra-assay CV ranges between 2–4%.
Association measures
The minimal model that is believed to underlie endocrine time
series data is composed of a secretion term and exponential decay,
together explaining the variation in hormone concentration [3]:
dx
dt
~bx(t)zw(t) ð1Þ
Equation 1 describes the changes in time t of the concentration x,
with b the decay constant and w the secretion term. The
identification of the parameters in such a model is not trivial as
the model is ill-posed; there is a trade off between the decay
constant (b) and the secretion (w). The model can successfully be
parametrized by explicitly enforcing the assumption of episodic
secretion through the constraint that the secretion term w should
have many zeros. Choosing the optimal number of zeros can be
performed by an appropriate model selection criterion [3].
The model of Equation 1 is used to extract the time series of
secretion pulses (w) from the hormone time series, which together
with the concentration level information (x) are used to construct a
series of association metrics. An example of a measured
Table 1. Estradiol levels in women were obtained in the (early) follicular phase of the menstrual cycle.
Basal characteristics of the volunteers
Subject Gender Age BMI Estradiol Testosterone IGF-1 fT4
yr kg=m2 pmol=L nmol=Ln m o l =Lp m o l =L
1 female 33 22.10 147 ND 18.9 15.5
2 male 36 21.60 57 15.7 23.8 21.2
3 female 33 20.59 85 ND 19.7 17.6
4 male 55 21.80 56 19.8 14.3 20.1
5 male 43 22.60 55 12.1 24.2 16.0
6 female 41 20.58 82 ND 30.6 16.5
7 male 44 22.69 54 19.1 12.3 19.6
8 female 34 20.42 40 ND 35.1 17.3
9 male 37 23.41 57 12.4 14.4 16.3
Testosterone levels in men were in the normal range (10–30 nmol/L). ND: not determined. Normal values for IGF-1 are age-dependent and range between 10–35 nmol/
L. Normal free thyroxine levels (fT4) are between 10–22 nmol/L. The BMI levels are all within the non-obese range.
doi:10.1371/journal.pone.0032985.t001
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shown in Figure 1.
Four association metrics that are specific implementations of the
cross-correlation function, exploit the covariation between hor-
mones considering both concentrations and secretion pulse
distribution and amplitudes. These metrics can be used to extract
information on regulation between hormones. Metric AM1
describes the association between the concentration time series
of two hormones. This first association metric is simply the cross-
correlation function of the concentration time series of two
hormones xa and xb (with t indicating the time lag, and r the
correlation coefficient):
AM1(t)~r(xa(izt),xb(i)) ð2Þ
AM2 describes in the same way the association between pulse time
series of two hormones:
AM2(t)~r(wa(izt),wb(i)) ð3Þ
Two other measures explicitly focus on the secretion induced
response, by conditioning the data series on (estimated) secretion
activity. One metric correlates the concentration levels of one
hormone with the secretion amplitude of the second hormone
conditional on the presence of secretion events of the second
(AM3). The other metric correlates the concentrations of both
hormones conditional on the presence of secretion events in one of
them (AM4).
The conditioning takes the time points at which secretion takes
place (wj(t)w0) as the conditioning vector (Equation 4), being a
subset of the original time vector.
Yb~fiDwb(i)w0g,i[ 1,2,   ,145 fg ð4Þ
where wb is the vector holding the secretion amplitudes of
hormone b and Yb is the set of secretion indices. The AM3 metric
uses the concentration of xa and the secretion wb conditional on
non zero secretion events in wb. It describes the association
between the concentration time series of one and the pulse time
series for another hormone selecting only those time points where
a pulse in this second hormone was observed.
AM3(t)~r(xa(izt),wb(i)),i[fYbgð 5Þ
The AM3 metric, since concentrations of the first hormone are
used, contains accumulated information about past events, in
contrast to AM2, where only information on the pulse moment is
considered. AM4 describes the association between the concen-
tration time series of both hormones considering only those time
indices that do pulse in one of the hormones.
AM4(t)~r(xa(izt),xb(i)),i[fYbgð 6Þ
Instead of pulse amplitude information, circulating hormone
concentration levels are used, which might give more powerful
evidence of the existence of a response in a to secretion pulses of b.
AM4, as compared to AM1, does not concentrate so much on
decay patterns, but more on secretion related phenomena.
Generally, cross-correlations are mirrored around lag zero,
when interchanging the labels a and b in equations 2 and 3. Since
both cross-correlation profiles will yield the same information, only
one of the two is depicted in the figures.
Figure 1. An example of measured 24-hr 10-minute interval serum hormone profiles. The dark line in the upper figure represents ACTH;
the estimated secretion is shown by the dark bars in the lower panel. In this system, ACTH pulses drive or elicit pulses of cortisol pulses with a delay of
approximately one time unit. Cortisol (light line, scaled by factor 0.1) also receives some pulse stimuli from auxiliary inputs as not all cortisol pulses are
preceded by an ACTH pulse (see the lower figure).
doi:10.1371/journal.pone.0032985.g001
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identical for the two hormones involved in the cross-correlation
calculation (Ya=Yb). This implies that two versions of the metrics
AM3 and AM4 exist. One where conditioning is on the secretion
pulses of a and one for conditioning on pulses in b.
Inhibition is common in biology, and inhibitory actions can be
found on the molecular level and on higher levels involving
complex tissue responses, see Figure 2 subfigure 3. For this reason
a simulation example was set up that mimicked inhibition in
pulsatile systems. To this end, two sets of unrelated pulses were
constructed by random sampling. The pulse series of hormone a
was integrated to give concentration values. Then the pulse series
of hormone b was adapted such that when the concentration in a
exceeded a threshold value, the pulses in b were reduced in
amplitude by 90%. The resulting concentration and pulse series
were then analyzed by the different association metrics.
The paper’s objective is to show that regulation mechanisms can
be extracted from hormone concentration data by using the
proposed association metrics. To this end five different common
types of regulatory mechanisms were studied, (1) rapid activation
with lag (a activates b), (2) concentration threshold activation, (3)
inhibition (b inhibits a), (4) a combination of inhibition and
activation, (5) diurnal patterns, without direct action of one
hormone on the other (see Figure 2 for a schematic representation
of the regulatory mechanisms).
For each of the five types of regulatory triggering mechanisms a
hundred time series were simulated and, when available,
compared with real measured data (see Suppporting Information
S1 for a description of the simulations). The results of the
measured data series are shown with the 95% confidence interval
of the mean. The confidence statistics are calculated on the Fisher-
Z transformed correlation values after which the confidence
interval values are transformed back to the normal correlation
space. The result of this operation is that the confidence intervals
are not symmetric about the mean. The case of rapid activation
will be discussed and illustrated at length to show the
Figure 2. Schematic depiction of the simulated regulatory mechanisms in episodic secreting hormones. (1) Shows a mechanism in
which a pulse in a triggers a pulse in b.( 2) Shows a mechanism that triggers a pulse to be released in b when a falls below a (preset) threshold. (3)
Shows a mechanism that inhibits the pulse amplitude in b when the concentration in a is above a (preset) threshold. (4) Shows that combining
mechanisms (1) and (2) appear as mechanism (1).(5) Depicts a diurnal pattern that is maintained by another (shared) variable.
doi:10.1371/journal.pone.0032985.g002
Detecting Regulatory Mechanisms
PLoS ONE | www.plosone.org 4 March 2012 | Volume 7 | Issue 3 | e32985interpretation of the metrics. It will be shown that it is possible to
extract certain regulatory mechanisms from time series data.
Results
Rapid activation
In a stimulatory system consisting of two hormones, a and b,a
pulse in a translates into a pulse in b. This activation system is the
simplest link between two hormones as all that is required is a
receptor, and a signal transduction cascade that triggers the
secretion of the other hormone into the circulation, see subfigure 1
in Figure 2.
The pulses in a are followed by the pulses in b which, in this
simulation study, are lagging by one sampling unit. There are no
additional inputs to b nor is there any other source of noise or
(measurement) error introduced in this simulation.
In Figure 3 AM1 shows a clear optimum at lag 1, which
matches the designed delay between pulses of the two hormones.
AM2, representing the cross-correlation between pulse profiles,
shows clearer that there is a nonzero relation between a and b at
lag 1. At other lags (by design) there is no relation, which is better
represented in AM2 than in AM1. AM3 shows the relation
between the pulse amplitude of one hormone at time indices with
actual secretion and the concentration of a second hormone. The
black solid line shows that the pulses in a correlate strongest with
the concentration of b at lag 1. It is noteworthy that before lag 1
there is no correlation between the pulse amplitude and the
concentration. At high lags correlations are present, which are due
to the correlation of the pulse of a with the exponential decay
profile of b. Conversely, the dashed line shows that the pulses in b
correlate strongest with the concentration in a at lag 21. As is
expected, on the solid line, there is a non zero relation after lag 21
and no relation before lag 21. AM4 shows the relation between
the concentrations at time indices with actual secretion; the cross-
correlation profiles depend on the secretion of a and b. The black
solid line is based on conditioning on the pulses in a while the
dashed line is produced by conditioning on the pulses in b. Both
show a clear peak at lag 1.
An introduction of variation in the lag, being either 1 or 2 lags,
when generating simulated data, is reflected in the association
metrics (see Figure 4). Along with the previous simulation model
pulse-to-pulse variation in the lag, with which a pulse in hormone
a induces a pulse in hormone b, is introduced. Optimum values of
the association values are now found at lag 1 as well as lag 2.
The association measures were applied to times series
measurements of adrenocorticotropic hormone (ACTH) and
cortisol from 9 healthy and lean subjects. Figure 5 shows the
association measures describing the relation between the two
hormones. The presented cross correlation profiles are averages
over individual profiles. Pulse profiles were estimated from the
concentration time series using a method described in [3]. The
relation between ACTH and cortisol is well known, there is rapid
activation of the secretion of cortisol by ACTH. AM1 and AM2
point to some optimum at lag 1, though AM2 shows that the
correlation at lag 0 is unequal to zero. Moreover, the true lag may
be smaller than 10 minutes, e.g., between lag 0 and 1. The results
are similar to those shown in Figure 4, though AM2 is much less
pronounced. The latter is likely caused by subject to subject
variation in the optima of AM2. The AM3 results are different
from those of the simulation study. It is postulated here that this
difference is related to temporal clustering of pulses and the
circadian rhythm that are not included in the simulation model.
The slight differences observed between AM4 and the simulation
model need to be interpreted in the same terms.
Threshold activation
An activating system is considered which creates a single trigger
secretion pulse in b when the concentration of a falls below a
Figure 3. Pulses in a induce pulses in b after 1 lag, without auxiliary (noise) pulses in b. The solid black lines represent the cross correlation
profiles after conditioning on a, the dashed lines after conditioning on pulses in b.
doi:10.1371/journal.pone.0032985.g003
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related to conditioning on pulses of a and the dashed line on the pulses of b.
doi:10.1371/journal.pone.0032985.g004
Figure 5. Overview of the metrics on the HPA axis hormones ACTH and cortisol. The shaded area around the white lines marks the 95%
confidence interval of the mean, the thin lines show the individual results. The four metrics unanimously point to lag 1, but the different metrics
center on different aspects of the relation between ACTH and cortisol.
doi:10.1371/journal.pone.0032985.g005
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activating system that yields strikingly different results, as shown in
Figure 6, when compared to the rapid activation system. The
AM1 and AM2 results are weakly negative from lag 0 and up, as
expected, since low concentrations of hormone a, will induce
pulses in b and therefore show negative correlation patterns. The
AM3 elucidates a striking pattern in the relation between pulses of
b and the concentrations of a. The conditioning on pulses of b
correlates these pulses with the decaying pattern of hormone a
before it drops below the threshold, when it induces a pulse in b.
The patterns for the four association metrics are very different for
rapid activation and threshold activation, serving the goal of this
study.
Inhibition
Figure 7 shows that inhibition can be identified by negative
associations, especially for the concentration based measures AM1
and AM4. When the concentration in a is high it will diminish the
secretion of b. The small values for the associations as measured
with AM2 are caused by the fact that the pulses of a and b are
generated randomly and independently. The negative associations
found for inhibition contrast with the positive associations found
for rapid activation, and with the very distinguishing patterns for
concentration threshold activation.
Activation and inhibition
Many biological systems are thought of as being regulated by a
combination of activation and inhibition, see Figure 2 subfigure 4.
The tight integration of the two mechanisms especially allows for a
finely regulated system. This poses some intriguing questions for
the analysis as variation is believed to be dominated by secretion.
When the negative inhibition becomes active, the new secretion
episodes are dampened, meaning that active inhibition cannot be
detected directly but needs to be deduced from the absence (or
diminishing amplitudes) of secretion pulses in the inhibition target.
Mechanistically, this system can be a self limiting system composed
of two components. Some formalized argumentation is provided in
the Supporting Information S1 (see Equations S.13, S.14 and
S.15). The result of the association metrics of a set of hormones in
a system with strong inhibition is shown in Figure 8. There are no
differences between Figure 8 and 3, indicating that the two systems
can not be distinguished from each other based on the proposed
metrics. The examination of the distribution of pulse amplitudes of
the inhibition target conditional on the (lagged) concentrations of
the inhibitor may reveal inhibition. However, for real data it is
questionable if this kind of information can be retrieved as data on
the inhibited as well as the uninhibited pulse amplitude
distributions need to be available.
Diurnal patterns
Many hormones are secreted in diurnal patterns. The processes
that drive the secretion of such hormones are not required to be
causally dependent on each other, see Figure 2 subfigure 5. No
physiological relation has to exist between the secretion pulses
other than the cyclical temporal association of the secretion
processes. The observed association patterns (Figure 9) are the
result of diurnal behavior that presents itself with similar
fluctuation patterns, apart from some time shift. This type of
associations shows a particular wave form and is most dominant
for the concentration profiles (AM1 and AM4).
An example of this type of association in real data is given in
Figure 10. The associations of ACTH and thyroid-stimulating
hormone (TSH) extracted from hormone concentration profiles of
9 lean controls, the AM1 and AM4 plots reveal similar patterns
with two optima. ACTH and TSH are not believed to directly
regulating each other. A potential modulator that regulates the
action of both hormones, can possibly found outside this two-
Figure 6. A concentration drop of a below a certain threshold induces a pulse in b. In AM3 and AM4 the solid line marks the conditioning
on pulses of a and the dashed line the pulses of b.
doi:10.1371/journal.pone.0032985.g006
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of b by 90%.
doi:10.1371/journal.pone.0032985.g007
Figure 8. The association metrics in a system in which a drives b with a time lag of one and b acts as an inhibitor when the
concentration of b exceeds a certain threshold such that the new pulses in a are reduced by 90%.
doi:10.1371/journal.pone.0032985.g008
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patterns, but without direct activation or inhibition.
doi:10.1371/journal.pone.0032985.g009
Figure 10. Overview of association metrics of ACTH and TSH. The shaded area around the white lines marks the 95% confidence interval of
the mean, the thin lines show the individual results. The metrics point at a relation at two optima at lags 242 and 22.
doi:10.1371/journal.pone.0032985.g010
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thyrotropin-releasing hormone (TRH) levels.
Discussion
The identification of pulse patterns in hormone concentration
time series, combined with the estimation of association measures
can reveal the functional relations between hormone pairs. Basic
biological regulatory mechanisms were investigated, and associa-
tion measures were evaluated on their ability to distinguish these
mechanisms. In a rapid activation system such as presented in two
simulation studies, the AM2 clearly unmasks the underlying
mechanism and is the best metric for this type of mechanism. This
was also confirmed by the real system of ACTH-cortisol
measurements. On the whole the mechanisms show distinct
association measure patterns, making it possible to determine
regulatory mechanisms based on hormone concentration profiles.
The exception is when activation is combined with inhibition.
Without additional information about the activation process, and
the secretion of the activating hormone, no information on the
inhibition can be extracted. Diurnal behavior of hormones also
shows distinct association patterns. This may give rise to the
hypothesis of the existence of a regulatory relation, however, the
associations are calculated within the ‘closed system’ assumption
which cannot exclude influences from outside the ‘system’. The
detected diurnal relations are, in a broader context, the result of
regulatory relations.
In the proposed explorative approach for revealing functional
relations, basal secretion is not included in the simulations, though
there are good indications that at least some hormones have a
basal secretion [1,7]. The undesired increase in the simulation
complexity is the reason for not including basal secretion. Another
motivation for not including basal secretion is that it can be hard
to identify without the (extensive) use of prior information.
The generic detection of relations in time series with episodic
activity was our motivation for developing an assumption-free set
of metrics to detect regulation and diurnal relations, which is what
we describe in this manuscript. An alternative strategy to using
association measures for the inference of (functional) relations
would be an approach where a pharmacological model, expressed
in differential equations, is used. Keenan and Veldhuis et al [8,9]
show that based on this approach dose-response curves can
explicitly be estimated based on time series hormone data. Keenan
and Veldhuis et al [8,9] showed that such an approach is tractable
and can provide valuable information about the differences
between, for instance, age groups. Our strategy, as described in
the method section, on the contrary, uses very few assumptions
and focuses on detecting relations, opposed to fitting a complex set
of equations to data.
In this study it is shown that regulatory mechanisms can be
detected in time series data. In hypothesis generation it is very
valuable to probe observed concentration profiles with the
association metrics that are proposed here. This approach can
be used to compare regulatory behavior between cohorts. Changes
in cross correlation profiles may point to changes in regulatory
behavior due to disease or treatment. This will be the subject of
future study.
Supporting Information
Supporting Information S1 The supplementary material
describes the mathematical details of the simulations.
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